Sitemap - 2024 - The Kable
π New funds for making in Africa; The Africa CDC makes some plans; India has a quality problem
π Africa goes traditional; A new cure for TB; Birds are real, so is bird flu
π Mpox continues to rampage in Africa; City living begins to crumble; Feeling superhot, hot, hot
π Mpox gets an official vaccine; Profits over people, always; Google's new drug designer
π Africa to finally get mpox vaccines; New antimicrobials from the gut; An antibiotic pandemic
π Gavi calls for $9 billion; Bird flu on the down low; Mpox rages in Africa
π BioMilk comes to Africa; Cadila Pharma goes to Russia; Bird flu? It's going everywhere
π CEPI does a lot of work; BioNTech gets money to build in Africa; New hope for birth control
π Sanofi and AI-driven drug discovery; Bird flu takes up news space; Oxford says PRESTO
π J&J makes a buy; GSK takes the fight to AMR; AbbVie bets billions on psychiatric disorders
π Novartis shells out the big bucks; From Africa for Africa; A new weapon against malaria?
πMerck digs deeper into ADCs; Vertex boosts immunology pipeline; J&J buys Shockwave
πAbbVie gets into colitis, Novo Nordisk digs deeper into cardio, Go West! To Pharmaconex
π AstraZeneca puts in $2 billion on radiopharma; Novo goes big in China; Merck bets big on Korea
π The new big pharma market; Big bucks queue up for Sanofi arm; Novavax makes a settlement
π Gilead bets on liver disease; EFTA bats for extended IP; Is long Covid really real?
π CEPI boost for PAHO; Novartis makes a buy; Novo Nordisk makes a buy too
π Gates Foundation expands budgets, WHO seeks funding; AlphaMind comes of age